3-phenyl-7-(propan-2-yloxy)-4H-chromen-4-one
| Title | Journal |
|---|---|
| Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology 20171201 |
| Mutagenicity of ipriflavone in vivo and in vitro. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120301 |
| Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study. | Biomedical chromatography : BMC 20120101 |
| [Effect of ipriflavone on Wistar rats and their litters]. | Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 20120101 |
| Discovery of indeno[1,2-c]quinoline derivatives as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL). | Journal of medicinal chemistry 20110428 |
| Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. | Toxicology in vitro : an international journal published in association with BIBRA 20100801 |
| Effects of ipriflavone on postmenopausal syndrome and osteoporosis. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100201 |
| Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091208 |
| Synthesis and anti-osteoporotic evaluation of certain 3-amino-2-hydroxypropoxyisoflavone derivatives. | European journal of medicinal chemistry 20090901 |
| [Effect of ipriflavone on growth and blood testosterone level in male rats]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20090501 |
| Determination of the anti-osteoporosis drug ipriflavone in pharmaceutical formulation by stripping voltammetric and chromatographic methods. | Journal of AOAC International 20090101 |
| Effects of phytoestrogen on mitochondrial structure and function of hippocampal CA1 region of ovariectomized rats. | Cellular and molecular neurobiology 20080901 |
| The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile. | Clinical nutrition (Edinburgh, Scotland) 20080801 |
| Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats. | Climacteric : the journal of the International Menopause Society 20080601 |
| Potential ipriflavone and warfarin interaction. | The American journal of medicine 20071201 |
| Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes. | Xenobiotica; the fate of foreign compounds in biological systems 20070301 |
| Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate. | Biopharmaceutics & drug disposition 20061001 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats. | The Journal of pharmacy and pharmacology 20060401 |
| Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males. | Journal of the International Society of Sports Nutrition 20060101 |
| The effect of two dietary and a synthetic phytoestrogen on transepithelial calcium transport in human intestinal-like Caco-2 cells. | European journal of nutrition 20050301 |
| Ipriflavone modulates IGF-I but is unable to restore bone in rats. | Phytotherapy research : PTR 20050201 |
| Induction of apoptosis in cultured rat gastric epithelial cells by ipriflavone: comparison with indomethacin. | Biological & pharmaceutical bulletin 20040501 |
| [Abnormality of bone mineral metabolism in type 2 diabetes mellitus]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Interaction between ipriflavone and other drugs in metabolism in vitro]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040101 |
| Inhibition of COX isoforms by nutraceuticals. | Journal of herbal pharmacotherapy 20040101 |
| Promoting effect of kaempferol on the differentiation and mineralization of murine pre-osteoblastic cell line MC3T3-E1. | Bioscience, biotechnology, and biochemistry 20030601 |
| Use of alternative and complementary medicine in menopause. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20021201 |
| Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model. | International journal of cancer 20020801 |
| Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research. | Urology 20020401 |
| [Comparative analyses on osteoporosis guidelines in Japan, EU and USA]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| Effects of ipriflavone on bone augmentation within a titanium cap in rabbit calvaria. | Journal of oral science 20020301 |
| Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects. | Life sciences 20020201 |
| Clinical effects of phytoestrogens. | Clinical obstetrics and gynecology 20011201 |
| Rapid improvement of osteomalacia by treatment in a case with Sjögren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1. | Internal medicine (Tokyo, Japan) 20010801 |
| Efficacy of ipriflavone in preventing adverse effects of leuprolide. | The Journal of clinical endocrinology and metabolism 20010701 |
| Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. | JAMA 20010321 |
| Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. | Endocrinology 19981001 |